secwatch.observer — SEC 8-K summary
======================================

Issuer:     Edgewise Therapeutics, Inc. (EWTX)
CIK:        0001710072
Form:       8-K
Filed at:   2024-08-12T23:59:59+00:00
Accession:  0001104659-24-088426
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Edgewise Therapeutics adopts 2024 Inducement Plan, reserving 2M shares for new hires
--------------------------------------------------------------------------------

- Board adopted 2024 Inducement Equity Incentive Plan effective August 10, 2024, reserving 2,000,000 shares of common stock.
- Plan allows grants of nonstatutory stock options, SARs, restricted stock, RSUs, and performance awards as hiring inducements.
- Adopted without stockholder approval under Nasdaq Listing Rule 5635(c)(4) – limited to new employees or merger hires.
- Terms are substantially similar to the 2021 Equity Incentive Plan; no Exchange Program is permitted.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1710072/000110465924088426/0001104659-24-088426-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1710072/000110465924088426/tm2421320d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-088426

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer